The electronic trial master file (eTMF) system market value in 2024 is estimated to be around US$ 1.7 billion, as per a recent report. Clinical trial conduct has increased, and eTMF software developers are supporting this trend by offering scalable and globally accessible eTMF hosting.
The adoption rate of eTMF in clinical trials is predicted to evolve at an impressive CAGR of 12.9% over the next ten years. The report further reveals the electronic trial master file (eTMF) system industry to reach a value of nearly US$ 5.8 billion by 2034 end.
Electronic Trial Master File (eTMF) System Market Trends & Analysis
| Report Attribute | Details |
|---|---|
| Market Revenue (2024) | US$ 1.7 billion |
| Market Anticipated Forecast Value (2034) | US$ 5.8 billion |
| Market Projected Growth Rate (2024 to 2034) | 12.9% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
According to the earlier market survey reports, the electronic trial master file (eTMF) system adoption in 2019 accrued revenue of around only US$ 0.9 billion in 2019. However, in the following years, the worldwide demand for eTMF validation and verification solutions skyrocketed, driving the overall market at an impressive 14.9% CAGR.
As clinical trials became more widespread, effective handling of clinical trial file management across many geographic locations became necessary during the pandemic years. By following this robust growth rate for the next five years, the total valuation of the market was figured out to have reached US$ 1.5 billion by 2023 end.
| Attributes | Details |
|---|---|
| Market Size (2019) | US$ 0.9 billion |
| Total Market Size (2023) | US$ 1.5 billion |
| Overall Market Growth (CAGR 2019 to 2023) | 14.9% |
The use of electronic trial file implementation is being propelled by digital transformation in clinical trials or preclinical research domain. Market players are expected to take more advantage of this trend to grow their business by providing cloud-based document management solutions that support further digitalization of operations.
The flexibility and responsiveness of clinical trial administration have improved these days with the development of modern TMF reference models with capabilities for instantaneous data retrieval and reporting. So, a greater focus on quality management and data compliance to ensure accuracy in clinical trials is expected to increase the eTMF integration with EDC systems and propel the market to new heights.
Principal Consultant
The table below represents the average pace of growth that the electronic trial master file (eTMF) system solution providers can expect to operate in some of the top-performing countries. Another table below predicts the total industry size in such countries by 2034 end, in terms of value, based on the present market expanse and forecasted growth rates.
| Regional Market Comparison | CAGR (2024 to 2034) |
|---|---|
| United States | 13% |
| Japan | 14.4% |
| United Kingdom | 13.8% |
| South Korea | 15.2% |
| China | 13.3% |
The United States currently dominates the electronic trial master file (eTMF) system market owing to the presence of many leading eTMF system vendors. As per the analysis report, the total demand for electronic trial master file (eTMF) systems in the United States is expected to increase at a rate of 13% over the next ten years.
The regional market has strengthened over the years by improving trial management efficiency, particularly through the integration of eTMF systems and CTMS. An ecosystem for clinical trials that is more coherent and effective is anticipated to create more opportunities for the United States market players in the coming days.
China currently accounts for nearly 40 to 50% of the total demand for electronic trial master file SOPs in Asia. As per the market forecasts, the China electronic trial master file system market is likely to witness a year-on-year growth rate of 13.3% through the forecast years.
The adoption of electronic trial master file (eTMF) systems in China increased as it gradually became critical to guarantee the security and integrity of clinical trial data. Moreover, the greater emphasis of the pharmaceutical companies operating in the country on expanding their market globally is expected to boost further the need for the best eTMF systems for pharma companies.
| Regional Market Size | Market Size by 2034 (by Value) |
|---|---|
| United States | US$ 1 billion |
| Japan | US$ 621 million |
| United Kingdom | US$ 230 million |
| South Korea | US$ 351 million |
| China | US$ 917.9 million |
Based on different components constituting the present market of electronic trial master file (eTMF) systems, the services segment currently dominates over the software segment. As per the market estimate report, the demand for eTMF training and support services is forecast to increase at a rate of 12.7% over the next ten years.
| Attributes | Details |
|---|---|
| Top Product Type | Services |
| CAGR from 2024 to 2034 | 12.7% |
| CAGR from 2019 to 2023 | 14.7% |
Among the different end users of trial documentation systems, pharmaceutical companies and biotechnology companies create more than 50% of the demand together. As per the market analysis, this segment is likely to expand further with an annual increment rate of 12.4% between 2024 and 2034.
| Attributes | Details |
|---|---|
| Top End User | Pharmaceutical and Biotechnology Companies |
| CAGR from 2024 to 2034 | 12.4% |
| CAGR from 2019 to 2023 | 14.6% |
The higher requirement for real-time access to trial data at pharmaceutical industries and biotechnology research centers is likely to retain its dominance through the projected years. However, the need for eTMF features and functionalities at contract research organizations (CROs) has soared to enable smooth cooperation across several stakeholders driving collaborative research activities. With the emergence of many new contract research organizations being observed lately, the share of this market segment is expected to rise in the coming days.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Large organizations are primarily drawn to electronic trial master file system developers who include strong data protection measures, encryption, and audit trails in their systems. So, a few leading players with higher credibility currently hold a significant share of the overall market and have rendered a consolidated nature. However, new entrants have recently made considerable advancements by developing clinical trial management software that offers accessible functionality and user-friendly interfaces.
Recent Developments in the Market
In September 2022, Montrium Company introduced two new services, TMF maturity educational training services and expert-led trial master file (TMF) services. These novel service packages have been designed to assist TMF teams and clinical operations at every phase of the clinical trial and its development process.
In June 2022, Anju Software Incorporate introduced a new cloud-based electronic trial master file software application by the name of eTMF Masterwas for its clients. This advanced solution facilitates cooperation between sponsors, CROs, and sites to effectively and securely handle clinical trial information in a cloud setting.
| Attribute | Details |
|---|---|
| Estimated Market Size (2024) | US$ 1.7 billion |
| Projected Market Size (2034) | US$ 5.8 billion |
| Anticipated Growth Rate (2024 to 2034) | 12.9% |
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2019 to 2023 |
| Market Analysis | US$ million or billion for Value and Units for Volume |
| Key Regions Covered | North America, Latin America, Europe, Middle East & Africa (MEA), East Asia, South Asia and Oceania |
| Key Countries Covered | United States, Canada, Brazil, Mexico, Germany, Spain, Italy, France, United Kingdom, Russia, China, India, Australia & New Zealand, GCC Countries, and South Africa |
| Key Segments Covered | By Component or Product Type, By Deployment Type, By Functionality, By End-user Verticals, and By Region |
| Key Companies Profiled |
|
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The electronic trial master file system market is valued at US$ 1.7 billion in 2024.
The electronic trial master file system market is to grow at 12.9% during the forecast period.
The electronic trial master file system market is predicted to be valued at US$ 5.8 billion by 2034.
The United States accounts for nearly 18% of the revenue share of the electronic trial master file system market.
South Korea is to witness a CAGR of 15.3% in sales of the electronic trial master file system through 2034.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034 4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023 4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Component 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Component, 2019 to 2023 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Component, 2024 to 2034 5.3.1. Software 5.3.2. Services 5.4. Y-o-Y Growth Trend Analysis By Component, 2019 to 2023 5.5. Absolute $ Opportunity Analysis By Component, 2024 to 2034 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Deployment Mode 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Deployment Mode, 2019 to 2023 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Deployment Mode, 2024 to 2034 6.3.1. Cloud/Web-Based 6.3.2. On-Premise 6.4. Y-o-Y Growth Trend Analysis By Deployment Mode, 2019 to 2023 6.5. Absolute $ Opportunity Analysis By Deployment Mode, 2024 to 2034 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By End User , 2019 to 2023 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User , 2024 to 2034 7.3.1. Pharmaceutical and Biotechnology Companies 7.3.2. Contract Research Organizations 7.3.3. Others 7.4. Y-o-Y Growth Trend Analysis By End User , 2019 to 2023 7.5. Absolute $ Opportunity Analysis By End User , 2024 to 2034 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034 8.3.1. North America 8.3.2. Latin America 8.3.3. Western Europe 8.3.4. Eastern Europe 8.3.5. South Asia and Pacific 8.3.6. East Asia 8.3.7. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 9.2.1. By Country 9.2.1.1. USA 9.2.1.2. Canada 9.2.2. By Component 9.2.3. By Deployment Mode 9.2.4. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Component 9.3.3. By Deployment Mode 9.3.4. By End User 9.4. Key Takeaways 10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Component 10.2.3. By Deployment Mode 10.2.4. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Component 10.3.3. By Deployment Mode 10.3.4. By End User 10.4. Key Takeaways 11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. UK 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Western Europe 11.2.2. By Component 11.2.3. By Deployment Mode 11.2.4. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Component 11.3.3. By Deployment Mode 11.3.4. By End User 11.4. Key Takeaways 12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 12.2.1. By Country 12.2.1.1. Poland 12.2.1.2. Russia 12.2.1.3. Czech Republic 12.2.1.4. Romania 12.2.1.5. Rest of Eastern Europe 12.2.2. By Component 12.2.3. By Deployment Mode 12.2.4. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Component 12.3.3. By Deployment Mode 12.3.4. By End User 12.4. Key Takeaways 13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Bangladesh 13.2.1.3. Australia 13.2.1.4. New Zealand 13.2.1.5. Rest of South Asia and Pacific 13.2.2. By Component 13.2.3. By Deployment Mode 13.2.4. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Component 13.3.3. By Deployment Mode 13.3.4. By End User 13.4. Key Takeaways 14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Component 14.2.3. By Deployment Mode 14.2.4. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Component 14.3.3. By Deployment Mode 14.3.4. By End User 14.4. Key Takeaways 15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Component 15.2.3. By Deployment Mode 15.2.4. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Component 15.3.3. By Deployment Mode 15.3.4. By End User 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2023 16.1.2.1. By Component 16.1.2.2. By Deployment Mode 16.1.2.3. By End User 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2023 16.2.2.1. By Component 16.2.2.2. By Deployment Mode 16.2.2.3. By End User 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2023 16.3.2.1. By Component 16.3.2.2. By Deployment Mode 16.3.2.3. By End User 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2023 16.4.2.1. By Component 16.4.2.2. By Deployment Mode 16.4.2.3. By End User 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2023 16.5.2.1. By Component 16.5.2.2. By Deployment Mode 16.5.2.3. By End User 16.6. UK 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2023 16.6.2.1. By Component 16.6.2.2. By Deployment Mode 16.6.2.3. By End User 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2023 16.7.2.1. By Component 16.7.2.2. By Deployment Mode 16.7.2.3. By End User 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2023 16.8.2.1. By Component 16.8.2.2. By Deployment Mode 16.8.2.3. By End User 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2023 16.9.2.1. By Component 16.9.2.2. By Deployment Mode 16.9.2.3. By End User 16.10. Poland 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2023 16.10.2.1. By Component 16.10.2.2. By Deployment Mode 16.10.2.3. By End User 16.11. Russia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2023 16.11.2.1. By Component 16.11.2.2. By Deployment Mode 16.11.2.3. By End User 16.12. Czech Republic 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2023 16.12.2.1. By Component 16.12.2.2. By Deployment Mode 16.12.2.3. By End User 16.13. Romania 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2023 16.13.2.1. By Component 16.13.2.2. By Deployment Mode 16.13.2.3. By End User 16.14. India 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2023 16.14.2.1. By Component 16.14.2.2. By Deployment Mode 16.14.2.3. By End User 16.15. Bangladesh 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2023 16.15.2.1. By Component 16.15.2.2. By Deployment Mode 16.15.2.3. By End User 16.16. Australia 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2023 16.16.2.1. By Component 16.16.2.2. By Deployment Mode 16.16.2.3. By End User 16.17. New Zealand 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2023 16.17.2.1. By Component 16.17.2.2. By Deployment Mode 16.17.2.3. By End User 16.18. China 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2023 16.18.2.1. By Component 16.18.2.2. By Deployment Mode 16.18.2.3. By End User 16.19. Japan 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2023 16.19.2.1. By Component 16.19.2.2. By Deployment Mode 16.19.2.3. By End User 16.20. South Korea 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2023 16.20.2.1. By Component 16.20.2.2. By Deployment Mode 16.20.2.3. By End User 16.21. GCC Countries 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2023 16.21.2.1. By Component 16.21.2.2. By Deployment Mode 16.21.2.3. By End User 16.22. South Africa 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2023 16.22.2.1. By Component 16.22.2.2. By Deployment Mode 16.22.2.3. By End User 16.23. Israel 16.23.1. Pricing Analysis 16.23.2. Market Share Analysis, 2023 16.23.2.1. By Component 16.23.2.2. By Deployment Mode 16.23.2.3. By End User 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Component 17.3.3. By Deployment Mode 17.3.4. By End User 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Aurea 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. Covance Inc. 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. Mastercontrol Inc. 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. Oracle 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. Transperfect 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. Veeva Systems 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. ePharmaSolutions 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.8. Phlex 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.9. SureClinical Inc 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Technology Insights
View Reports
Electronic Trial Master File (eTMF) System Market
